A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002369 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2007-10-02
Summary
To evaluate the tolerance, and comparative virologic and immunologic effects of the two combination regimens.
Conditions
- HIV Infections
Interventions
- DRUG
-
Indinavir sulfate
- DRUG
-
Lamivudine
- DRUG
-
Stavudine
- DRUG
-
Zidovudine
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
NCT00002199 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC
NCT00002208 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
NCT00002442 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients
NCT00002307 ·Status: COMPLETED ·Phase: NA
-
A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC
NCT00002155 ·Status: COMPLETED ·Phase: NA
-
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
NCT00002195 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
NCT00002379 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
NCT00541463 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)
NCT00002079 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
NCT00002241 ·Status: UNKNOWN ·Phase: PHASE2
-
The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment
NCT00005118 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
NCT00002400 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
NCT00002234 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
NCT00050895 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.
NCT00158821 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine
NCT00013897 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002389 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
NCT00002048 ·Status: COMPLETED ·Phase: NA
-
Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
NCT00000882 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
NCT00002406 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors
NCT00002361 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002443 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults
NCT02603107 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine
NCT00002371 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)
NCT00000649 ·Status: COMPLETED ·Phase: PHASE1